๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

1032 Evaluation of cytokine levels in prostate cancer patients undergoing radiotherapy

โœ Scribed by Daila S. Gridley; Jerry D. Slater; Leslie T. Yonemoto; Daniel W. Miller; Carl Rossi; John O. Archambeau; Melba L. Andres; Ming Oey; James M. Slater

Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
88 KB
Volume
32
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Prospective study of fatigue in localize
Prospective study of fatigue in localized prostate cancer patients undergoing radiotherapy
โœ Uma Monga; Anthony J. Kerrigan; John Thornby; Trilok N. Monga ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 136 KB ๐Ÿ‘ 2 views

The objectives were to (1) prospectively evaluate fatigue utilizing validated instruments in patients with localized prostate cancer, and (2) examine the relationships between fatigue, depression, quality of life, and sleep disturbance. The instruments used included: Piper Fatigue Scale, Beck Depres

Evaluation of glycoprotein constituents
Evaluation of glycoprotein constituents in head and neck cancer patients undergoing radiotherapy
โœ Rakesh M. Rawal; Prabhudas S. Patel; Beena P. Patel; Gira N. Raval; Mintoo M. Pa ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 138 KB ๐Ÿ‘ 2 views

Background. Alterations in serum levels of several glycoprotein constituents are reported to be useful for treatment monitoring of cancer patients. The purpose of this study was to determine efficacy of sialic acid and seromucoid fraction as treatment monitors for head and neck (H&N) cancer patients

Elevation of cytokine levels in cachecti
Elevation of cytokine levels in cachectic patients with prostate carcinoma
โœ Jesco Pfitzenmaier; Robert Vessella; Celestia S. Higano; Jennifer L. Noteboom; D ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 98 KB

## Abstract ## BACKGROUND Approximately 60โ€“70% of patients with advanced prostate carcinoma (CaP) suffer from cachexia, one of the most devastating conditions associated with advanced malignant disease. The pathophysiology of cachexia is multifactorial, and several cytokines, such as tumor necrosi